Resources Contact Us Home
Polynucleotides encoding myostatin binding agents

Image Number 6 for United States Patent #7803923.

The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity.

  Recently Added Patents
Vanadium, cobalt and strontium additives for use in aluminum back solar cell contacts
Systems and methods for advertising on content-screened web pages
Circuit device for preventing radiation emission in portable terminal with two cameras
Control device for radiation imaging apparatus and control method therefor
High damage threshold frequency conversion system
Optimized delivery of web application code
  Randomly Featured Patents
Inflatable seat belt with leak detection device
Technique for locating electronic labels in an electronic price display system
Process for producing carnosol from carnosic acid
Method and apparatus for generating and displaying multiple simultaneously-active windows
Injector for implanting a folded intraocular lens, container for storing and transporting the injector and method for ejecting the lens in a folded state
Memory device with reduced power dissipation
Motor driving device
High-speed fiber-to-the-premise optical communication system
Organic electrolytic cell
Image correcting apparatus and method, and image correction program